These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26946358)

  • 41. The P2X7/P2X4 interaction shapes the purinergic response in murine macrophages.
    Pérez-Flores G; Lévesque SA; Pacheco J; Vaca L; Lacroix S; Pérez-Cornejo P; Arreola J
    Biochem Biophys Res Commun; 2015 Nov; 467(3):484-90. PubMed ID: 26456657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S; Glockshuber R
    Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
    Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
    Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of P2X4 receptors induces an increase in the area of the extracellular region and a decrease in receptor mobility.
    Bergler F; Fuentes C; Kadir MF; Navarrete C; Supple J; Barrera NP; Edwardson JM
    FEBS Lett; 2020 Dec; 594(24):4381-4389. PubMed ID: 32979222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The cellular prion protein interacts with the tissue non-specific alkaline phosphatase in membrane microdomains of bioaminergic neuronal cells.
    Ermonval M; Baudry A; Baychelier F; Pradines E; Pietri M; Oda K; Schneider B; Mouillet-Richard S; Launay JM; Kellermann O
    PLoS One; 2009 Aug; 4(8):e6497. PubMed ID: 19652718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prion Protein Modulates Monoaminergic Systems and Depressive-like Behavior in Mice.
    Beckman D; Santos LE; Americo TA; Ledo JH; de Mello FG; Linden R
    J Biol Chem; 2015 Aug; 290(33):20488-98. PubMed ID: 26152722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resolving the Ionotropic P2X4 Receptor Mystery Points Towards a New Therapeutic Target for Cardiovascular Diseases.
    Bragança B; Correia-de-Sá P
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibiting the P2X4 Receptor Suppresses Prostate Cancer Growth In Vitro and In Vivo, Suggesting a Potential Clinical Target.
    He J; Zhou Y; Arredondo Carrera HM; Sprules A; Neagu R; Zarkesh SA; Eaton C; Luo J; Gartland A; Wang N
    Cells; 2020 Nov; 9(11):. PubMed ID: 33233569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flotillin-1 mediates PrPc endocytosis in the cultured cells during Cu²⁺ stimulation through molecular interaction.
    Ren K; Gao C; Zhang J; Wang K; Xu Y; Wang SB; Wang H; Tian C; Shi Q; Dong XP
    Mol Neurobiol; 2013 Dec; 48(3):631-46. PubMed ID: 23625312
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relative Role of Akt, ERK and CREB in Alcohol-Induced Microglia P2X4R Receptor Expression.
    Gofman L; Fernandes NC; Potula R
    Alcohol Alcohol; 2016 Nov; 51(6):647-654. PubMed ID: 26946194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tryptophan 46 is a site for ethanol and ivermectin action in P2X4 receptors.
    Popova M; Trudell J; Li K; Alkana R; Davies D; Asatryan L
    Purinergic Signal; 2013 Dec; 9(4):621-32. PubMed ID: 23817978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistochemical evidence of P2X7R, P2X4R and CaMKK2 in pyramidal neurons of frontal cortex does not align with Alzheimer's disease.
    Gaff J; Jackaman C; Papadimitriou J; Waters S; McLean C; Price P
    Exp Mol Pathol; 2021 Jun; 120():104636. PubMed ID: 33838119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human cellular prion protein interacts directly with clusterin protein.
    Xu F; Karnaukhova E; Vostal JG
    Biochim Biophys Acta; 2008 Nov; 1782(11):615-20. PubMed ID: 18786636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PrP
    Panes JD; Saavedra P; Pineda B; Escobar K; Cuevas ME; Moraga-Cid G; Fuentealba J; Rivas CI; Rezaei H; Muñoz-Montesino C
    Front Mol Neurosci; 2021; 14():762918. PubMed ID: 34880726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of the P2X4 receptor in trigeminal neuralgia, a common neurological disorder.
    Lu MX; Liu ZX
    Neuroreport; 2021 Mar; 32(5):407-413. PubMed ID: 33661807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correction: Spatial quality control bypasses cell-based limitations on proteostasis to promote prion curing.
    Klaips CL; Hochstrasser ML; Langlois CR; Serio TR
    Elife; 2015 Jan; 4():e06494. PubMed ID: 25626954
    [No Abstract]   [Full Text] [Related]  

  • 57. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
    Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
    Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual role of ribosome-associated chaperones in prion formation and propagation.
    Chernoff YO; Kiktev DA
    Curr Genet; 2016 Nov; 62(4):677-685. PubMed ID: 26968706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New Light on Prions: Putative Role of PrP
    Chrobak AA; Pańczyszyn-Trzewik P; Król P; Pawelec-Bąk M; Dudek D; Siwek M
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pore forming channels as a drug delivery system for photodynamic therapy in cancer associated with nanoscintillators.
    Alves LA; Ferreira LB; Pacheco PF; Mendivelso EAC; Teixeira PCN; Faria RX
    Oncotarget; 2018 May; 9(38):25342-25354. PubMed ID: 29861876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.